Skip to content

China Greenlight Registry Study (Post-market)

Prospective Registry of Outcomes With the GreenLight™ Laser System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03736512
Enrollment
30
Registered
2018-11-09
Start date
2019-02-27
Completion date
2021-11-29
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia (BPH)

Brief summary

The duration of the study is expected to take approximately 3 years, which includes a recruitment period of approximately 12-months and 2 years (24-months) to complete procedure and follow-up visits.

Detailed description

The study follow-up duration from the primary study procedure is 5 years. * Baseline * Study Procedure * 4-week * 6-month * 12-month * 24-month (End of Study) The study will be considered complete after all subjects have completed the 24-month follow-up visit.

Interventions

DEVICEGreenLight XPS™ 532 nm Laser System with MoXy™ laser fiber

observational registry

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject has provided informed consent and agrees to attend all study visits * Subject has a diagnosis of lower urinary tract symptoms due to benign prostatic enlargement causing bladder outlet obstruction * Subject is able to complete self-administered questionnaires * Clinical investigator has documented in the subject's medical record that in his/her judgment the subject is a surgical candidate for the PVP procedure * Subject is ≥ 40 years of age * Subject has an IPSS score greater than or equal to 12 measured at the baseline visit * Subject has medical record documentation of a maximum urinary flow rate (Qmax) less than or equal to 15ml/s and sample is greater than or equal to 150ml (If uroflow testing documentation is available within 90 days prior to the informed consent date, and the sample is greater than or equal to 150ml, and the Qmax is less than or equal to 15ml/s it may be used for the inclusion/

Exclusion criteria

) * Subject has medical record documentation of a prostate volume of greater than or equal to 30 grams by transrectal ultrasound (TRUS))

Design outcomes

Primary

MeasureTime frameDescription
The GreenLight XPS system provides durable relief of BPH symptoms in subjects.6-month follow upChanges of IPSS Scores in subjects treated with the GreenLight XPS Laser System at 6 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026